New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO study" in JU ...
Cure Today25d
mpMRI Improves Initial Staging in Suspected Muscle-Invasive Bladder Cancer
Conducted in 17 UK hospitals, the study involved 143 patients, comparing mpMRI and TURBT pathways for staging bladder cancer. The mpMRI pathway allowed for faster treatment initiation, with a median ...
Hosted on MSN1mon
Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
A total of 638 patients were screened between May 31, 2018, and Dec. 31, 2021, and 143 were randomly assigned to TURBT or initial mpMRI (72 and 71, respectively). Thirty-six of 39 participants ...
Photocure: New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...